UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Cognitive decline in Huntington's disease expansion gene carriers

Baake, V; Reijntjes, RHAM; Dumas, EM; Thompson, JC; Roos, RAC; Bentivoglio, AR; Biunno, I; ... REGISTRY Investigators, European Huntington's Disease Network, .; + view all (2017) Cognitive decline in Huntington's disease expansion gene carriers. Cortex , 95 pp. 51-62. 10.1016/j.cortex.2017.07.017. Green open access

[thumbnail of Baake_Cognitive_decline_Huntington's.pdf]
Preview
Text
Baake_Cognitive_decline_Huntington's.pdf - Accepted Version

Download (397kB) | Preview

Abstract

BACKGROUND: In Huntington's Disease (HD) cognitive decline can occur before unequivocal motor signs become apparent. As cognitive decline often starts early in the course of the disease and has a progressive nature over time, cognition can be regarded as a key target for symptomatic treatment. The specific progressive profile of cognitive decline over time is unknown. OBJECTIVE: The aim of this study is to quantify the progression of cognitive decline across all HD stages, from pre-motormanifest to advanced HD, and to investigate if CAG length mediates cognitive decline. METHODS: In the European REGISTRY study 2669 HD expansion gene carriers underwent annual cognitive assessment. General linear mixed models were used to model the cognitive decline for each cognitive task across all disease stages. Additionally, a model was developed to evaluate the cognitive decline based on CAG length and age rather than disease stage. RESULTS: There was significant cognitive decline on all administered tasks throughout pre-motormanifest (close to estimated disease onset) participants and the subsequent motormanifest participants from stage 1 to stage 4. Performance on the Stroop Word and Stroop Color tests additionally declined significantly across the two pre-motormanifest groups: far and close to estimated disease onset. The evaluation of cognition performance in relation to CAG length and age revealed a more rapid cognitive decline in participants with longer CAG length than participants with shorter CAG length over time. CONCLUSION: Cognitive performance already shows decline in pre-motormanifest HD gene expansion carriers and gradually worsens to late stage HD. HD gene expansion carriers with certain CAG length have their own cognitive profile, i.e., longer CAG length is associated with more rapid decline.

Type: Article
Title: Cognitive decline in Huntington's disease expansion gene carriers
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.cortex.2017.07.017
Publisher version: https://doi.org/10.1016/j.cortex.2017.07.017
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Huntington's disease, Cognition, Longitudinal, REGISTRY
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery.ucl.ac.uk/id/eprint/10044788
Downloads since deposit
511Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item